High dose cytarabine (HiDAC) with amsacrine (AMSA) for relapsed and refractory adult lymphoblastic leukemia (ALL): Ongoing single institution experience

被引：0
|
作者：
Monahan, BP
Dahut, WL
机构：
[1] NATL NAVAL MED CTR, DIV HEMATOL, BETHESDA, MD USA
[2] NATL NAVAL MED CTR, DIV MED ONCOL, BETHESDA, MD USA
来源：
BLOOD | 1995年 / 86卷 / 10期
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：3072 / 3072
页数：1
相关论文
共 50 条
  • [1] Cytarabine with a single high dose of idarubicin as induction therapy for adults with relapsed or refractory acute lymphoblastic leukemia (ALL).
    Weiss, MA
    Aliff, TB
    Tallman, MS
    Frankel, SR
    Kalaycio, ME
    Maslak, PG
    Scheinberg, DA
    Roma, TE
    BLOOD, 2000, 96 (11) : 719A - 719A
  • [2] AMSACRINE WITH HIGH-DOSE CYTARABINE IS HIGHLY EFFECTIVE THERAPY FOR REFRACTORY AND RELAPSED ACUTE LYMPHOBLASTIC-LEUKEMIA IN ADULTS
    ARLIN, ZA
    FELDMAN, E
    KEMPIN, S
    AHMED, T
    MITTELMAN, A
    SAVONA, S
    ASCENSAO, J
    BASKIND, P
    SULLIVAN, P
    FUHR, HG
    MERTELSMANN, R
    BLOOD, 1988, 72 (02) : 433 - 435
  • [3] HIGH-DOSE AMSACRINE (AMSA) THERAPY OF RELAPSED AND REFRACTORY ADULT ACUTE NONLYMPHOCYTIC LEUKEMIA - A PHASE-II STUDY
    CASSILETH, PA
    LYMAN, GH
    BENNETT, JM
    GLICK, JH
    OKEN, MM
    AMERICAN JOURNAL OF CLINICAL ONCOLOGY-CANCER CLINICAL TRIALS, 1984, 7 (04): : 361 - 363
  • [4] Rescue therapy combining intermediate-dose cytarabine with amsacrine and etoposide in relapsed adult acute lymphoblastic leukemia
    Reman, O
    Buzyn, A
    Lhéritier, V
    Huguet, F
    Kuentz, M
    Stamatoullas, A
    Delannoy, A
    Fegueux, N
    Micléa, JM
    Boiron, JM
    Vernant, JP
    Gardin, C
    Hacini, M
    Georges, M
    Fière, D
    Thomas, X
    HEMATOLOGY JOURNAL, 2004, 5 (02) : 123 - 129
  • [5] Clofarabine Based Chemotherapy in Adult Relapsed/Refractory Acute Lymphoblastic Leukemia/Lymphoma-a Single Institution Experience
    Alkhateeb, Hassan B.
    Damlaj, Moussab
    Lin, Tasha
    Al-Kali, Aref
    Sproat, Lisa
    Betcher, Jeffrey Alan
    Barreto, Jason N.
    Hashmi, Shahrukh K.
    Patnaik, Mrinal M.
    Gangat, Naseema
    Elliott, Michelle
    Litzow, Mark R.
    Hogan, William J.
    BLOOD, 2015, 126 (23)
  • [6] A phase I trial of a single high dose of idarubicin combined with high dose cytarabine (ARA-C) as induction therapy in relapsed or refractory adult patients with acute lymphoblastic leukemia (ALL).
    Weiss, M
    Maslak, P
    Megherian, L
    Scheinberg, D
    BLOOD, 1995, 86 (10) : 3131 - 3131
  • [7] A phase I trial of a single high dose of idarubicin combined with high-dose cytarabine as induction therapy in relapsed or refractory adult patients with acute lymphoblastic leukemia
    Weiss, MA
    Drullinsky, P
    Maslak, P
    Scheinberg, D
    Golde, DW
    LEUKEMIA, 1998, 12 (06) : 865 - 868
  • [8] High Dose Cytarabine and Clofarabine (HiDAC→CLOF) in Relapsed or Refractory Acute Myeloid Leukemia, a Phase 2 Trial.
    Powell, Bayard
    D'Agostino, Ralph, Jr.
    Levitan, Denise
    Ellis, Leslie Renee
    Lyerly, Susan
    Skiles, Megan
    Manuel, Megan
    Harrelson, Robin
    Kimbrough, Claire
    Hurd, David Duane
    BLOOD, 2008, 112 (11) : 676 - 676
  • [9] A phase I trial of a single high dose of idarubicin combined with high-dose cytarabine as induction therapy in relapsed or refractory adult patients with acute lymphoblastic leukemia
    MA Weiss
    P Drullinsky
    P Maslak
    D Scheinberg
    DW Golde
    Leukemia, 1998, 12 : 865 - 868
  • [10] IDARUBICIN AND HIGH-DOSE CYTARABINE IN THE TREATMENT OF REFRACTORY AND RELAPSED ACUTE LYMPHOBLASTIC-LEUKEMIA
    GIONA, F
    TESTI, AM
    AMADORI, S
    MELONI, G
    CAROTENUTO, M
    RESEGOTTI, L
    COLELLA, R
    LEONI, P
    CARELLA, AM
    GROTTO, P
    MINIERO, R
    MANDELLI, F
    ANNALS OF ONCOLOGY, 1990, 1 (01) : 51 - 55
12345